Evidence map›Paper›PMID 27893352›Full record

ArticleBlood transfusion = Trasfusione del sangue2018

Prevalence of antibodies to a new histo-blood system: the FORS system.

Carlos Jesus, Camilla Hesse, Clara Rocha, Nádia Osório, Ana Valado, Armando Caseiro, António Gabriel, Lola Svensson, Ali-Reza Moslemi, Wafa Abu Siba and 5 more

Open access · greenAbstract read
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. A bifunctionalOrganic & biomolecular chemistry · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Expression of theTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Carlos JesusBiomedical Sciences Department of ESTESC - Coimbra Health School, Polytechnic Institute of Coimbra, Coimbra, Portugal.
Camilla HesseDepartment for Clinical Chemistry and Transfusion Medicine, Institute for Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Clara RochaPolytechnic Institute of Coimbra, ESTESC-Coimbra Health School, Department Complementary Sciences, Coimbra, Portugal.
Nádia OsórioBiomedical Sciences Department of ESTESC - Coimbra Health School, Polytechnic Institute of Coimbra, Coimbra, Portugal.
Ana ValadoBiomedical Sciences Department of ESTESC - Coimbra Health School, Polytechnic Institute of Coimbra, Coimbra, Portugal.
Armando CaseiroBiomedical Sciences Department of ESTESC - Coimbra Health School, Polytechnic Institute of Coimbra, Coimbra, Portugal.
António GabrielBiomedical Sciences Department of ESTESC - Coimbra Health School, Polytechnic Institute of Coimbra, Coimbra, Portugal.
Lola SvenssonDepartment for Clinical Chemistry and Transfusion Medicine, Institute for Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Ali-Reza MoslemiDepartment of Pathology, Institute for Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Wafa Abu SibaDepartment of Medical Laboratory Sciences, Faculty of Health Professions, Al-Quds University, East Jerusalem, Palestine.
Mahmoud A SrourDepartment of Medical Laboratory Sciences, Faculty of Health Professions, Al-Quds University, East Jerusalem, Palestine.
Cristina PereiraBlood and Transfusion Medicine Department, Coimbra Hospital and University Centre (CHUC), Coimbra, Portugal.
Jorge TomazBlood and Transfusion Medicine Department, Coimbra Hospital and University Centre (CHUC), Coimbra, Portugal.
Paulo TeixeiraBiomedical Sciences Department of ESTESC - Coimbra Health School, Polytechnic Institute of Coimbra, Coimbra, Portugal.
Fernando MendesBiomedical Sciences Department of ESTESC - Coimbra Health School, Polytechnic Institute of Coimbra, Coimbra, Portugal.
Al-Quds University · PSUniversity of Gothenburg · SEEscola Superior de Tecnologia da Saúde de Coimbra · PTUniversity of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 1987, three unrelated English families were reported with a putative blood subgroup called A MATERIALS AND

methodsPlasma samples from 800 individuals were studied. Sheep erythrocytes or Forssman "kodecytes" were mixed with the plasma samples using the tube technique. Plasma from an A

resultsOf the 800 individuals tested, one was negative for the presence of anti-Forssman antibody. We compared the anti-Forssman antibody reaction pattern between genders and found that males have weaker reactions than females, both at room temperature (p=0.026) and at 37 °C (p=0.043). We also investigated the reaction pattern of anti-Forssman antibody in relation to ABO and Rh blood group types without finding any significant differences. DISCUSSION: Sheep erythrocytes are suitable for searching for human anti-Forssman antibody. The quantity of anti-Forssman antibodies in plasma is higher in females than in males. In the population (n=800) studied here, we found one individual lacking the anti-Forssman antibody. These results contribute to the data already published, confirming that FORS is a rare blood group.

Indexed as

AnimalsBlood Group AntigensBlood Grouping and CrossmatchingFemaleForssman AntigenHumansIsoantibodiesMaleOligosaccharidesPrevalenceSheepBlood Group AntigensForssman AntigenForssman pentasaccharideIsoantibodiesOligosaccharides

Identifiers

PMID27893352
PMCPMC5839615
OpenAlexW2558640006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.